<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Supp/Chondroitin_Sulfate.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:34:07 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="2828008">
<meta name="Category" content="Supp">
<meta name="Article" content="Chondroitin_Sulfate">
<title>Sulfato de Condroitina-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Sulfato de Condroitina</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Chondroitin_Sulfate.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Moss M, Kruger GO, Reynolds DC. The effect of chondroitin sulfate on bone
healing. <em>Oral Surg Oral Med Oral Pathol</em> 1965;20:795-801.</li>

<li class="Ref">Rovetta G. Galactosaminoglycuronoglycan sulfate (Matrix) in therapy of
tibiofibular osteoarthritis of the knee. <em>Drugs Exptl Clin Res</em> 1991;17:53-7.</li>

<li class="Ref">Mazieres B, Loyau G, Menkes CJ, et al. Le chondroitine sulfate dans le
traitement de la gonarthrose et de la coxarthrose. <em>Rev Rhum Mal Steoartic</em>
1992;59:466-72 [in French].</li>

<li class="Ref">Uebelhart D, Chantraine A. Efficacit&#231;&#376;&#163;linique du sulfate de
chondroitine dans la gonarthrose: &#232;&#179;&#181;de randomis&#232;&#163;&nbsp;en
doubl&#232;&#163;&#173;insu versus plac&#232;&#161;&#175;. <em>Rev Rhum</em> 1994;10:692 [in
French]</li>

<li class="Ref">Morreale P, Manopulo P, Galati M, et al. Comparison of the anti-inflammatory
efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis.
<em>J Rheumatol</em> 1996;23:1385-91.</li>

<li class="Ref">Bourgeois P, Chales G, Dehais J, et al. Efficacy and tolerability of
chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo. <em>
Osteoarthritis Cartilage</em> 1998;6(Supplement A):25-30.</li>

<li class="Ref">Verbruggen G, Goemaere S, Veys EM. Chondroitin sulfate: S/DMOAD
(structure/disease modifying anti-osteoarthritis drug) in the treatment of finder joint OA.
<em>Osteoarthritis Cartilage</em> 1998;6(Supplement A):37-8.</li>

<li class="Ref">Bucsi L, Po&#242;&#176;&#376;. Efficacy and tolerability of oral chondroitin
sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of
knee osteoarthritis. <em>Osteoarthritis Cartilage</em> 1998;6(Supplement A):31-6.</li>

<li class="Ref">Uebelhart D, Thonar EJ-MA, Delmas PD, et al. Effects of oral chondroitin
sulfate on the progression of knee osteoarthritis: a pilot study. <em>Osteoarthritis
Cartilage</em> 1998;6(Supplement A):39-46.</li>

<li class="Ref">Kerzberg EM, Roldan EJA, Castelli G, Huberman ED. Combination of
glycosaminoglycans and acetylsalicylic acid in knee osteoarthritis. <em>Scand J Rheumatol</em>
1987;16:377-380.</li>

<li class="Ref">Izuka K, Murata K, Nakazawa K, et al. Effects of chondroitin sulfates on serum
lipids and hexosamines in atherosclerotic patients: with special reference to thrombus
formation time. <em>Jpn Heart J</em> 1968;9:453-60.</li>

<li class="Ref">Morrison LM, Bajwa GS, Alfin-Slater RB, Ershoff BH. Prevention of vascular
lesions by chondroitin sulfate A in the coronary artery and aorta of rats induced by a
hypervitaminosis D, cholesterol-containing diet. <em>Atherosclerosis</em> 1972;16:105-18.</li>

<li class="Ref">Morrison LM, Branwood AW, Ershoff BH, et al. The prevention of coronary
arteriosclerotic heart disease with chondroitin sulfate A: preliminary report. <em>Exp Med
Surg</em> 1969;27:278-89.</li>

<li class="Ref">Morrison LM, Enrick NL. Coronary heart disease: Reduction of death rate by
chondroitin sulfate A. <em>Angiology</em> 1973;24:269-82.</li>

<li class="Ref">Lenclud C, Chapelle P, van Mylem A, et al. Effects of chondroitin sulfate on
snoring characteristics: a pilot study. <em>Curr Ther Res</em> 1998;59:234-43.</li>

<li class="Ref">Baggio B, Gambaro G, Marchini F, et al. Correction of erythrocyte
abnormalities in idiopathic calcium-oxalate nephrolithiasis and reduction of urinary oxalate
by oral glycosaminoglycans. <em>Lancet</em> 1991;338:403-5.</li>

<li class="Ref">Cao LC, Boev&#231;&#376;...R, de Bruihn WC, et al. Glycosaminoglycans and
semisynthetic sulfated polysaccharides: an overview of their potential application in
treatment of patients with urolithiasis. <em>Urology</em> 1997;50:173-83 [review].</li>

<li class="Ref">Ronca F, Palmieri L, Panicucci P, Ronca G. Anti-inflammatory activity of
chondroitin sulfate. <em>Osteoarthritis Cartilage</em> 1998;6(Supplement A):14&#8211;21.</li>

<li class="Ref">De Klerk DP, Lee DV, Human HJ. Glycosaminoglycans of human prostatic cancer.
<em>J Urol</em> 1984;131:1008&#8211;12.</li>

<li class="Ref">Ricciardelli C, Quinn DI, Raymond WA, et al. Elevated levels of peritumoral
chondroitin sulfate are predictive of poor prognosis in patients treated by radical
prostatectomy for early-stage prostate cancer. <em>Cancer Res</em> 1999;59:2324&#8211;8.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Supp/Chondroitin_Sulfate.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:34:07 GMT -->
</html>

